Navigation Links
abciximab in Medical News

The Benefits of abciximab with clopidogrel for percutaneous coronary intervention Questioned

Primary findings from the Intracoronary Stenting and Antithrombotic Regimen-Rapid// Early Action for Coronary Treatment Trial (ISAR-REACT) has indicated that abciximab use in patients undergoing percutaneous coronary intervention (PCI) after pretreatment with 600 mg clopidogrel for less than 2 hour...

The future of interventional cardiology presented at TCT 2008

...l Infarction Undergoing Primary Percutaneous Coronary Intervention After Thienopyridine Loading FATA: A Prospective Randomized Trial of Tirofiban and abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention HORIZONS-AMI: A Prospective Randomized Trial of Pa...

TCT update: press conference schedule announced for TCT

...l Infarction Undergoing Primary Percutaneous Coronary Intervention After Thienopyridine Loading FATA: A Prospective Randomized Trial of Tirofiban and abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention HORIZONS-AMI: A Prospective Randomized Trial of Pa...

Anticoagulant Drugs Had Similar Outcomes After Angioplasty

...ients who had angioplasty, the anticoagulant drugs abciximab and tirofiban produced similar outcomes for certai...ear in the April 16 print issue. Treatment with abciximab and implantation of an uncoated stent is a treatme...sn't been clear whether using tirofiban instead of abciximab would provide similar benefits. They added that th...

Comparison of anticoagulants for angioplasty show similar outcomes

...lasty following a heart attack, the anticoagulants abciximab and tirofiban had similar outcomes for some cardia...d in the April 16 issue of JAMA. Infusion with abciximab and implantation of an uncoated-stent is a treatme...whether there may be similar benefits in replacing abciximab with tirofiban, which could have clinical and econ...

New Anti-Clotting Drug Shows Promise in Heart Patients

...he heart in patients undergoing PCI. "Preliminary clinical events did not show any differences, therefore eptifibatide seems a valid alternative to abciximab in patients with primary PCI," said Uwe Zeymer, lead author of the study, which was conducted out of Ludwigshafen, Germany, and funded by GlaxoSmithKl...
abciximab in Medical Technology

BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack

With high-dose clopidogrel, the intravenous anti-platelet drug appears unnecessary CHICAGO, March 30 /PRNewswire/ -- Over the years, interventional cardiologists have made many improvements in percutaneous coronary intervention (PCI) for patients with heart attack...

Drug-Eluting Stents Outperform Bare Stents in Heart Attack

...onale for high-dose tirofiban as an alternative to abciximab in patients with STEMI," said Marco Valgimigli, MD... Patients were randomly assigned to an infusion of abciximab or high-dose tirofiban (25 microgram/kg) and, in a... equivalent in the two groups (83.6 percent in the abciximab group vs. 85.3 percent in the tirofiban group). In...

Positive Aggrastat Results Featured in the Journal of the American College of Cardiology

...RATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus abciximab and Bare Metal Stent In Acute Myocardial Infarction) study were published i...STRATEGY (Multicentre Evaluation of Single High-Dose Bolus Tirofiban Versus abciximab and Sirolimus-Eluting Stent Versus Base Metal Stent in Acute Myocardial Inf...
abciximab in Medical Products

VerifyNow IIb/IIIa Assay

Description:...e instrument uses light transmittance to measure the rate at which this clearing occurs. If the GP IIb/IIIa receptors on the platelet are inhibited by abciximab or eptifibatide, there will be minimal binding of the microbeads with activated platelets, since the GP IIb/IIIa receptor sites are blocked by the dru...
Company:Accumetrics

VerifyNow System

Description:...d a result in minutes. VerifyNow IIb/IIIa, the first assay developed for use on the system is to assess GP IIb/IIIa platelet inhibition in response to abciximab or eptifibatide. VerifyNow Aspirin, the second assay developed for use on the system is to aid in the detection of platelet dysfunction due to aspirin...
Company:Accumetrics
abciximab in Biological News

UCSD researchers create roadmap to integrin activation

... integrin on the cell's surface to get sticky. Direct inhibitors of GPIIb-IIIa binding include antithrombotics such as eptifibatide (Integrelin), abciximab (Reopro), and tirofiban (Aggrestat), drugs that reduce thrombosis, or formation of blood clots, by binding to the receptors and completely blocking th...
Other Tags
(Date:3/28/2015)... Orlando, FL (PRWEB) March 28, 2015 ... pre-existing conditions coverage is made available to all visitors ... States, effective immediately. All members are encouraged to purchase ... finalized to avoid lack of proper coverage for pre-existing ... suffer from one or two medical conditions with serious ...
(Date:3/28/2015)... March 28, 2015 How best to ... growing field in orthopaedic medicine. While diagnostic hip injections ... confirm the pain etiology, research presented today at the ... Specialty Day suggests that pain relief from this diagnostic ... surgery. , “Our study looked to assess if ...
(Date:3/28/2015)... March 28, 2015 Lately the ... regarding recent changes and proposals around the NCAA. In ... and former collegiate student-athletes across a spectrum of universities ... on common challenges. The special panel consists of athletes ... sports ranging from football, track and field, baseball, and ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 ARDX will sponsor ... from 12pm -3pm at the Chesapeake Conference Center in Chesapeake, ... sponsoring an empowering event for women in the Hampton Roads ... the Stories of Women’s Lives. Women grow stronger through ... each other. This year the WWC™ theme is T-talk ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Wellness for ... and business criteria for the spa and wellness industry–has ... clients who have experienced or are living with cancer. ... Spafinder Wellness 365® Network, will be identified with a ... as a provider of safe, therapeutic services for cancer ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ... - Global Strategic Business Report" report to their offering. ... Geometry in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Rest of World. Annual estimates and forecasts are ...
(Date:3/18/2015)... -- As mobile payments become more prevalent amongst ... apps continue to be introduced into the market place at ... industry in focus today are:  NXT-ID, Inc. (NASDAQ: ... ), Apple Inc. (NASDAQ: AAPL ), Google Inc. ... FB ) NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
Other Contents